<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02402907</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 14-1410</org_study_id>
    <nct_id>NCT02402907</nct_id>
  </id_info>
  <brief_title>STRIPES Study: Study To Reduce Infection Post cEsarean Section</brief_title>
  <official_title>A Randomized Trial to Determine if a Pre-operative Wash With a Chlorhexidine Cloth Reduces Infectious Morbidity in Patients Undergoing Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine if the use of chlorhexidine gluconate cloths&#xD;
      prior to cesarean section reduce the rate of infectious morbidity (i.e. surgical site&#xD;
      infections, endometritis).&#xD;
&#xD;
      The study will be offered to women who present for a scheduled primary or repeat cesarean&#xD;
      section at Mount Sinai Medical Center. The eligible women will be randomized to use of a 2%&#xD;
      chlorhexidine gluconate (CHG) cloth or placebo cloth (a fragrance free cleansing cloth) the&#xD;
      night before and the morning of their scheduled procedure. Participants will be blinded to&#xD;
      the arm in which they have been assigned. This study intends to show that the use of 2% CHG&#xD;
      cloths prior to cesarean section will reduce the rate of surgical site infections.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chlorhexidine is a sterile, germ-free solution, which is regularly used to clean the skin&#xD;
      immediately before surgery and works by killing or preventing the growth or spread of&#xD;
      bacteria. Data exists in both the orthopedic and cardiac literature to show that an&#xD;
      additional preoperative use of chlorhexidine further reduces the risk of post procedure&#xD;
      infections. Limited data exists regarding the use of a preoperative use of chlorhexidine in&#xD;
      patients undergoing Obstetric or Gynecologic procedures and there is no wash or cloth used&#xD;
      prior to cesarean section as a standard of care. The hope for this study is to identify if an&#xD;
      additional preoperative chlorhexidine wash will further decrease or prevent infection in&#xD;
      women who deliver their babies via cesarean section.&#xD;
&#xD;
      All patients with a scheduled cesarean section surgery will be approached for enrollment&#xD;
      during their pre-admission testing visit on the labor floor 2 days before the scheduled&#xD;
      cesarean section, a visit that is standard procedure for this surgery. Once a patient is&#xD;
      consented, she will be randomly assigned to one of the 2 arms of the study: the eligible&#xD;
      women will be randomized to use of 2% chlorhexidine gluconate (CHG) cloths or placebo cloths&#xD;
      (a fragrance free cleansing cloths) on the body the night before and the morning of their&#xD;
      scheduled procedure. Participants will be blinded to the arm in which they have been&#xD;
      assigned.&#xD;
&#xD;
      The purpose of this study is to determine if the use of 2% chlorhexidine gluconate cloths&#xD;
      prior to cesarean section reduces the rate of surgical site wound infection and/or postpartum&#xD;
      endometritis, which is an infection or inflammation of the endometrium (the inner lining of&#xD;
      the uterus).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">October 11, 2019</completion_date>
  <primary_completion_date type="Actual">October 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Incisional SSI</measure>
    <time_frame>at 6 weeks</time_frame>
    <description>Number of participants with Incisional Surgical Site Infection (SSI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Adherent Participants With Incisional SSI</measure>
    <time_frame>at 6 weeks</time_frame>
    <description>Among those with full adherence to the protocol and who were available for assessment at 6 weeks. Adherence to the protocol was assessed in the following 2 ways: evaluation of returned packages on the day of surgery and report ascertained by phone interview at 2 weeks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Endometritis</measure>
    <time_frame>at 6 weeks</time_frame>
    <description>Number of participants with endometritis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Maternal Complications</measure>
    <time_frame>up to 6 weeks</time_frame>
    <description>Number of participants with maternal complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Neonatal ICU Admissions</measure>
    <time_frame>up to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Length of Stay</measure>
    <time_frame>at 6 weeks</time_frame>
    <description>Length of stay (index hospitalization)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Maternal Readmissions</measure>
    <time_frame>up to 6 weeks</time_frame>
    <description>Number of participants with hospital readmission for wound complication</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1356</enrollment>
  <condition>Chlorhexidine Gluconate Cloths</condition>
  <condition>Infection; Cesarean Section</condition>
  <condition>Infectious Morbidity</condition>
  <condition>Surgical Site Infections</condition>
  <condition>Endometritis</condition>
  <arm_group>
    <arm_group_label>CHG cloth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2% chlorhexidine gluconate (CHG) cloth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo cloth</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A fragrance free cleansing cloth</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2% chlorhexidine gluconate (CHG) cloth</intervention_name>
    <description>administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
    <arm_group_label>CHG cloth</arm_group_label>
    <other_name>CHG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo cloth</intervention_name>
    <description>administration of a cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
    <arm_group_label>Placebo cloth</arm_group_label>
    <other_name>Cleansing cloth</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women&#xD;
&#xD;
          -  &gt; 24 weeks gestation&#xD;
&#xD;
          -  scheduled for a primary or repeat cesarean section&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  allergy to chlorhexidine&#xD;
&#xD;
          -  unplanned or emergency cesarean section&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne Stone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>March 25, 2015</study_first_submitted>
  <study_first_submitted_qc>March 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2015</study_first_posted>
  <results_first_submitted>October 16, 2020</results_first_submitted>
  <results_first_submitted_qc>October 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 9, 2020</results_first_posted>
  <last_update_submitted>October 16, 2020</last_update_submitted>
  <last_update_submitted_qc>October 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Joanne L Stone</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>chlorhexidine gluconate</keyword>
  <keyword>CHG</keyword>
  <keyword>surgical site infection</keyword>
  <keyword>obstetrics</keyword>
  <keyword>infection prevention</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Endometritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 31, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/07/NCT02402907/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>1356 were enrolled, 14 did not undergo procedure at Sinai, leaving 1342 participants (672 in experimental group and 670 in placebo group) that continued on the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CHG Cloth</title>
          <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
        </group>
        <group group_id="P2">
          <title>Placebo Cloth</title>
          <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="682"/>
                <participants group_id="P2" count="674"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="662"/>
                <participants group_id="P2" count="647"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Delivered vaginally</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Delivered outside of Sinai</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to follow up after C-Section</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CHG Cloth</title>
          <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
        </group>
        <group group_id="B2">
          <title>Placebo Cloth</title>
          <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="682"/>
            <count group_id="B2" value="674"/>
            <count group_id="B3" value="1356"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Maternal age</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.1" spread="5.0"/>
                    <measurement group_id="B2" value="35.1" spread="5.0"/>
                    <measurement group_id="B3" value="35.1" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="682"/>
                    <measurement group_id="B2" value="674"/>
                    <measurement group_id="B3" value="1356"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Black or African American</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="436"/>
                    <measurement group_id="B2" value="416"/>
                    <measurement group_id="B3" value="852"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                    <measurement group_id="B2" value="121"/>
                    <measurement group_id="B3" value="234"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Private Insurance</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="604"/>
                    <measurement group_id="B2" value="577"/>
                    <measurement group_id="B3" value="1181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pregestational Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Asthma</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primiparous</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="248"/>
                    <measurement group_id="B2" value="236"/>
                    <measurement group_id="B3" value="484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Repeat Cesarean Delivery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="387"/>
                    <measurement group_id="B2" value="394"/>
                    <measurement group_id="B3" value="781"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preeclampsia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cholestasis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Estimated Blood loss</title>
          <population>Data results only for those participants who underwent C-Section at Sinai</population>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="672"/>
                    <count group_id="B2" value="670"/>
                    <count group_id="B3" value="1342"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="719.5" lower_limit="479.5" upper_limit="800.0"/>
                    <measurement group_id="B2" value="717.5" lower_limit="484.0" upper_limit="800"/>
                    <measurement group_id="B3" value="718.5" lower_limit="479.5" upper_limit="800"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Length of procedure</title>
          <population>Data results only for those participants who underwent C-Section at Sinai</population>
          <units>min</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="672"/>
                    <count group_id="B2" value="670"/>
                    <count group_id="B3" value="1342"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.0" lower_limit="53.0" upper_limit="74.0"/>
                    <measurement group_id="B2" value="62.0" lower_limit="53.0" upper_limit="76.0"/>
                    <measurement group_id="B3" value="62.0" lower_limit="53.0" upper_limit="76.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preincision Prophylactic Antibiotics</title>
          <population>Data results only for those participants who underwent C-Section at Sinai</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Clindamycin/gentamicin</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="672"/>
                    <count group_id="B2" value="670"/>
                    <count group_id="B3" value="1342"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cefazolin</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="645"/>
                    <measurement group_id="B2" value="648"/>
                    <measurement group_id="B3" value="1293"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Skin Closure Type</title>
          <population>Data results only for those participants who underwent C-Section at Sinai</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Staples</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="672"/>
                    <count group_id="B2" value="670"/>
                    <count group_id="B3" value="1342"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subcuticular suture</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="682"/>
                    <count group_id="B2" value="674"/>
                    <count group_id="B3" value="1356"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="616"/>
                    <measurement group_id="B2" value="612"/>
                    <measurement group_id="B3" value="1228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Incisional SSI</title>
        <description>Number of participants with Incisional Surgical Site Infection (SSI)</description>
        <time_frame>at 6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CHG Cloth</title>
            <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Cloth</title>
            <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Incisional SSI</title>
          <description>Number of participants with Incisional Surgical Site Infection (SSI)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="662"/>
                <count group_id="O2" value="647"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Adherent Participants With Incisional SSI</title>
        <description>Among those with full adherence to the protocol and who were available for assessment at 6 weeks. Adherence to the protocol was assessed in the following 2 ways: evaluation of returned packages on the day of surgery and report ascertained by phone interview at 2 weeks.</description>
        <time_frame>at 6 weeks</time_frame>
        <population>participants with full adherence to protocol and available for assessment at 6 weeks</population>
        <group_list>
          <group group_id="O1">
            <title>CHG Cloth</title>
            <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Cloth</title>
            <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Adherent Participants With Incisional SSI</title>
          <description>Among those with full adherence to the protocol and who were available for assessment at 6 weeks. Adherence to the protocol was assessed in the following 2 ways: evaluation of returned packages on the day of surgery and report ascertained by phone interview at 2 weeks.</description>
          <population>participants with full adherence to protocol and available for assessment at 6 weeks</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="524"/>
                <count group_id="O2" value="515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Endometritis</title>
        <description>Number of participants with endometritis</description>
        <time_frame>at 6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CHG Cloth</title>
            <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Cloth</title>
            <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Endometritis</title>
          <description>Number of participants with endometritis</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="662"/>
                <count group_id="O2" value="647"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Maternal Complications</title>
        <description>Number of participants with maternal complications</description>
        <time_frame>up to 6 weeks</time_frame>
        <population>Data results only for those participants who underwent C-Section at Sinai</population>
        <group_list>
          <group group_id="O1">
            <title>CHG Cloth</title>
            <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Cloth</title>
            <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Maternal Complications</title>
          <description>Number of participants with maternal complications</description>
          <population>Data results only for those participants who underwent C-Section at Sinai</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="672"/>
                <count group_id="O2" value="670"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Erythema at operative site</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Separation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drainage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Neonatal ICU Admissions</title>
        <time_frame>up to 6 weeks</time_frame>
        <population>Data not collected</population>
        <group_list>
          <group group_id="O1">
            <title>CHG Cloth</title>
            <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Cloth</title>
            <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Neonatal ICU Admissions</title>
          <population>Data not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maternal Length of Stay</title>
        <description>Length of stay (index hospitalization)</description>
        <time_frame>at 6 weeks</time_frame>
        <population>data for participants who were hospitalized</population>
        <group_list>
          <group group_id="O1">
            <title>CHG Cloth</title>
            <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Cloth</title>
            <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Maternal Length of Stay</title>
          <description>Length of stay (index hospitalization)</description>
          <population>data for participants who were hospitalized</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="652"/>
                <count group_id="O2" value="651"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="3.0" upper_limit="3.0"/>
                    <measurement group_id="O2" value="3.0" lower_limit="3.0" upper_limit="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Maternal Readmissions</title>
        <description>Number of participants with hospital readmission for wound complication</description>
        <time_frame>up to 6 weeks</time_frame>
        <population>Data results only for those participants who underwent C-Section at Sinai. unable to obtain data for 2 participants in placebo cloth arm</population>
        <group_list>
          <group group_id="O1">
            <title>CHG Cloth</title>
            <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Cloth</title>
            <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Maternal Readmissions</title>
          <description>Number of participants with hospital readmission for wound complication</description>
          <population>Data results only for those participants who underwent C-Section at Sinai. unable to obtain data for 2 participants in placebo cloth arm</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="672"/>
                <count group_id="O2" value="668"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>CHG Cloth</title>
          <description>2% chlorhexidine gluconate (CHG) cloth: administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
        </group>
        <group group_id="E2">
          <title>Placebo Cloth</title>
          <description>Placebo cloth: administration of a fragrance free cleansing cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="672"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="670"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="672"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="670"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="672"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="670"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations included the lower than anticipated rate of SSIs after scheduled cesarean deliveries, suggesting the possibility that the study was underpowered for the primary outcome. High rate of private insurance may limit generalizability.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Joanne Stone</name_or_title>
      <organization>Icahn School of Medicine at Mount Sinai</organization>
      <phone>212-241-5681</phone>
      <email>joanne.stone@mssm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

